Published in J Biol Chem on February 15, 1992
Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes. Am J Hum Genet (1993) 1.18
Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1). Blood (2007) 1.09
Biased exon/intron distribution of cryptic and de novo 3' splice sites. Nucleic Acids Res (2005) 1.08
The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements. Mol Cell Biol (1994) 1.05
Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis (2011) 1.04
Demystified...adhesion molecule deficiencies. Mol Pathol (2001) 0.85
A novel CD18 genomic deletion in a patient with severe leucocyte adhesion deficiency: a possible CD2/lymphocyte function-associated antigen-1 functional association in humans. Immunology (2000) 0.82
Two Novel Frame Shift, Recurrent and De Novo Mutations in the ITGB2 (CD18) Gene Causing Leukocyte Adhesion Deficiency in a Highly Inbred North African Population. J Biomed Biotechnol (2001) 0.77
Biology and structure of leukocyte β 2 integrins and their role in inflammation. F1000Res (2016) 0.76
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood (1989) 5.08
Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell (1995) 4.73
A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity (1996) 4.03
Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. J Clin Invest (1991) 3.67
Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest (1983) 3.23
Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure (1995) 3.15
Subcellular localization of the large subunit of Mo1 (Mo1 alpha; formerly gp 110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest (1984) 3.01
Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest (2001) 2.79
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A (2001) 2.62
Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J Clin Invest (1984) 2.57
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest (1984) 2.46
Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol (1986) 2.45
Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest (1984) 2.29
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int (1999) 2.17
A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell (1993) 2.15
p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol (1985) 2.14
Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int (2006) 2.10
Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J Cell Biol (1993) 1.96
Neutrophil migration across a cultured epithelial monolayer elicits a biphasic resistance response representing sequential effects on transcellular and paracellular pathways. J Cell Biol (1992) 1.89
Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol (2000) 1.84
An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem (2000) 1.84
Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol (1989) 1.82
Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest (1986) 1.76
Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol (1998) 1.67
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67
Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med (1985) 1.55
Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. J Immunol (1981) 1.55
Direct interaction of filamin (ABP-280) with the beta 2-integrin subunit CD18. J Immunol (1995) 1.53
Gastroduodenal inflammation in patients with non-ulcer dyspepsia. A controlled endoscopic and morphometric study. Dig Dis Sci (1985) 1.45
Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18). Proc Natl Acad Sci U S A (1994) 1.39
Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology (1983) 1.35
Prominent and sustained up-regulation of gp130-signaling cytokines and the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation (2000) 1.33
Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood (1989) 1.32
Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules. Eur J Immunol (1983) 1.25
IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury. J Leukoc Biol (2001) 1.12
Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease? Microvasc Res (2008) 1.12
Outside-in signaling by lipopolysaccharide through a tailless integrin. J Immunol (1997) 1.11
The promoter of the CD11b gene directs myeloid-specific and developmentally regulated expression. Proc Natl Acad Sci U S A (1991) 1.09
Expression of a soluble and functional form of the human beta 2 integrin CD11b/CD18. Proc Natl Acad Sci U S A (1991) 1.08
Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol (1991) 1.08
Solvent-accessible residues on the metal ion-dependent adhesion site face of integrin CR3 mediate its binding to the neutrophil inhibitory factor. J Biol Chem (1996) 1.08
Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines. J Biol Chem (1984) 1.07
The A-domain of beta 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J Cell Biol (1994) 1.06
Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol (2000) 1.05
Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release. J Immunol (1982) 1.05
The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements. Mol Cell Biol (1994) 1.05
Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am J Respir Crit Care Med (1995) 1.04
The modulated expression of Mo5, a human myelomonocytic plasma membrane antigen. Blood (1985) 1.04
Complement-dependent histaminase release from human granulocytes. J Clin Invest (1979) 1.04
Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis. Clin Exp Immunol (2009) 1.04
The changing epidemiology of diphtheria in Jordan. Bull World Health Organ (1988) 1.01
Endocytic vesicles from renal papilla which retrieve the vasopressin-sensitive water channel do not contain a functional H+ ATPase. J Cell Biol (1990) 1.01
The CD11/CD18 integrins: characterization of three novel LPS signaling receptors. Prog Clin Biol Res (1998) 1.01
Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int (1995) 0.99
Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med (1996) 0.99
Leukocytes from four patients with complete or partial Leu-CAM deficiency contain the common beta-subunit precursor and beta-subunit messenger RNA. J Clin Invest (1987) 0.98
Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain. J Immunol (1995) 0.98
LFA-1 beta-chain synthesis and degradation in patients with leukocyte-adhesive proteins deficiency. Eur J Immunol (1987) 0.98
Modulation of surface CD11/CD18 glycoproteins (Mo1, LFA-1, p150,95) by human mononuclear phagocytes. Clin Immunol Immunopathol (1988) 0.97
Complement C3 receptors: structure and function. Mol Immunol (1984) 0.97
Deficiency of two human leukocyte surface membrane glycoproteins (Mo1 and LFA-1). Fed Proc (1985) 0.97
Polycystin-1 interacts with intermediate filaments. J Biol Chem (2001) 0.97
Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations. Am J Transplant (2009) 0.94
Identification of cell-specific and developmentally regulated nuclear factors that direct myeloid and lymphoid expression of the CD11a gene. Proc Natl Acad Sci U S A (1993) 0.93
Identity of Wegener's autoantigen (p29) with proteinase 3 and myeloblastin. Blood (1990) 0.93
Cytoplasmic tails of human complement receptor type 3 (CR3, CD11b/CD18) regulate ligand avidity and the internalization of occupied receptors. J Immunol (1993) 0.92
Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? N Engl J Med (1977) 0.91
Solubilization of C3 fragments deposited on cross-linked dextran gel beads. Clin Immunol Immunopathol (1979) 0.91
Genetic susceptibility to renal ischemia reperfusion injury revealed in a murine model. Transplantation (2000) 0.91
Emerging paradigms of integrin ligand binding and activation. Kidney Int (1997) 0.90
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int (2001) 0.90
Integrins, cations and ligands: making the connection. J Thromb Haemost (2003) 0.90
Molecular cloning of a novel human hsp70 from a B cell line and its assignment to chromosome 5. J Immunol (1993) 0.90
The delayed effect of growth hormone on renal function in humans. Kidney Int (1989) 0.90
Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. Front Biosci (2000) 0.90
rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. Am J Transplant (2011) 0.88
Recombinant integrin CD11b A-domain blocks polymorphonuclear cells recruitment and protects against skeletal muscle inflammatory injury in the rat. Immunology (2006) 0.87
Genomic profiling of kidney ischemia-reperfusion reveals expression of specific alloimmunity-associated genes: Linking "immune" and "nonimmune" injury events. Transplant Proc (2006) 0.87
Antineutrophil cytoplasmic autoantibody-associated vasculitis presenting as Sjögren's syndrome. Arthritis Rheum (1992) 0.86
Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation. Transplant Proc (2006) 0.85
Ischemic-reperfusion injury in the kidney: overexpression of colonic H+-K+-ATPase and suppression of NHE-3. Kidney Int (1997) 0.85
Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int (2001) 0.85
An emerging paradigm shift on the role of leukocyte adhesion molecules. J Clin Invest (1997) 0.85
Functional analysis of the beta 2 integrins. Methods Mol Biol (1999) 0.85
Induction of the CD11b gene during activation of the monocytic cell line U937 requires a novel nuclear factor MS-2. J Immunol (1996) 0.84
Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera. J Immunol (1977) 0.84
Integrin-ligand interactions: scratching the surface. Curr Opin Hematol (1997) 0.83
A possible molecular basis of natriuresis during ischemic-reperfusion injury in the kidney. J Am Soc Nephrol (1998) 0.83
High altitude living: genetic and environmental adaptation. Aviat Space Environ Med (1999) 0.83
Multiple primary malignancies in a renal transplant patient. Transplantation (1996) 0.82
Protective role of selectin ligand inhibition in a large animal model of kidney ischemia-reperfusion injury. Kidney Int (2006) 0.82
Human complement receptor type 3. Methods Enzymol (1987) 0.82
Comparing methods for monitoring serum creatinine to predict late renal allograft failure. Am J Kidney Dis (2001) 0.82
Interaction of purified human proteinase 3 (PR3) with reconstituted lipid bilayers. Eur J Biochem (1999) 0.81
N-terminal sequence of human leukocyte glycoprotein Mo1: conservation across species and homology to platelet IIb/IIIa. Biochim Biophys Acta (1986) 0.81